Search results
- 4.7600Add to watchlist-0.2500 (-4.99%)At close:4:00 PM EDTWed. May 1, 20244.7300 -0.03 (-0.63%)After hrs:7:37 PM EDTWed. May 1, 2024Nasdaq Real Time Price (USD) · Market closed
- Open4.7500High5.0791Low4.5530
- Mkt Cap2.81MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close5.010052 Wk. Low4.380052 Wk. High93.7500
Related stocks
Apr 24, 2024 · MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and ...
- Avenue Therapeutics, Inc. (ATXI) Stock Price, News, Quote ...
ADILAdial Pharmaceuticals, Inc. 1.7000. +0.59%. Find the...
- Avenue Therapeutics Announces Closing of $12 Million ...
ATXI. Avenue Therapeutics. NEW YORK, Oct. 11, 2022 (GLOBE...
- Avenue Therapeutics, Inc. (ATXI) Stock Price, News, Quote ...
View Avenue Therapeutics, Inc. ATXI stock quote prices, financial information, real-time forecasts, and company news from CNN.
Oct 7, 2022 · Avenue Therapeutics (ATXI) is down 10.8% after-hours after the firm has priced its underwritten public offering of 3,636,365 common and pre-funded units.Each common unit consists of...
6 days ago · Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering. MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of th... 6 months ago - GlobeNewsWire.
Get the latest Avenue Therapeutics (ATXI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.